What Is The Right Way To Eat Chia Seeds, According To A Gut Health Expert
From breakfast bowls to detox drinks, chia seeds have quietly slipped into our daily routines. Once considered exotic, these tiny black seeds are now a common sight in Indian kitchens, thanks to their impressive nutritional profile and ease of use. Whether stirred into smoothies, soaked into puddings, or sprinkled over salads, chia seeds are being embraced by health-conscious individuals across the country. Their ability to support digestion, hydration, and heart health has made them a go-to ingredient for those seeking simple, plant-based wellness solutions. But as Harvard and AIIMS-trained gastroenterologist Dr Saurabh Sethi points out, not all methods of consuming chia seeds are equally beneficial. In fact, how we consume chia seeds matters just as much as why we choose them.
Also Read: Chia Seeds In Water: Does This New Weight Loss Hack Actually Work
The Nutritional Powerhouse: What Makes Chia Seeds A Superfood?
Despite being minuscule in size, chia seeds deliver substantial nutritional benefits:
1. Packed with fibre:
Mostly soluble, around 28 grams of chia seeds contain 10 grams of fibre, according to USDA data. This aids digestion, supports healthy gut bacteria, and helps you feel full for longer.
2. Rich in omega-3 fatty acids:
Chia seeds are among the richest plant-based sources of alpha-linolenic acid (ALA), an essential omega-3 fatty acid. ALA supports heart health by reducing inflammation, lowering LDL cholesterol, and improving blood vessel function. Several studies have also linked ALA to improved cognitive function and overall brain health.
3. Complete protein source:
A serving of chia seeds (about two tablespoons) contains around 4.7 grams of protein and provides all nine essential amino acids, making it a rare complete protein among plant foods. This helps stabilise blood sugar, supports muscle repair, and contributes to satiety.
4. Mineral-enriched:
Calcium: Two tablespoons provide about 18% of the daily requirement, supporting bone density and muscle function.
Magnesium: Essential for over 300 enzymatic reactions, including nerve transmission and energy production.
Iron: Vital for oxygen transport in the blood and preventing fatigue.
Phosphorus: Works with calcium to build strong bones and teeth, and supports cellular repair.
5. Provides essential antioxidants:
Chia seeds are rich in polyphenolic antioxidants like quercetin, chlorogenic acid, caffeic acid, and kaempferol. These compounds help neutralise free radicals, reducing oxidative stress and inflammation.
Also Read: Can Eating Chia Seeds Every Morning Help With Fat Loss? Here's The Truth
Photo Credit: iStock
What Are The Best Ways To Consume Chia Seeds? Top 3 Picks By The Expert
1. Chia Pudding:
This is one of the most recommended ways to consume chia seeds because soaking them breaks down enzyme inhibitors and makes them easier on the digestive system. "When soaked overnight, chia seeds develop a gel-like texture that eases digestion and enhances nutrient absorption," says Dr Sethi.
How to make it:
Soak 1 tablespoon of chia seeds in half a cup of milk (dairy or plant-based) for at least 2 hours. Add fruits, cinnamon, or a natural sweetener of your choice.
2. Chia Fresca:
A traditional Latin American drink that has found fans in India too, chia fresca is hydrating and gentle on the stomach. "Chia seeds swell during this rest period, making them safer and more effective for consumption," Dr Sethi explains.
How to make it:
Stir 1 tablespoon of chia seeds into a glass of water. Let it rest for 10-15 minutes. Add lemon or lime juice and a dash of honey or rock salt. Drink up!
3. Soaked And Blended Into Smoothies:
Soaked chia seeds can be blended into smoothies for a creamy consistency without the digestive strain of raw seeds. "When blended after soaking, chia seeds are unlikely to cause discomfort or create blockages in the digestive tract," says Dr Sethi.
How to make it:
Soak the seeds in water or milk for 10-15 minutes before blending. This also prevents them from forming a gel later in the stomach, which can otherwise feel heavy or lead to bloating.
How Not To Consume Chia Seeds:
Avoid eating them dry:
Dr Sethi strongly advises against consuming chia seeds raw or dry. "Chia seeds can absorb several times their weight in water. If consumed dry, especially before drinking water, they may swell in the oesophagus and pose a choking risk," he explains. This is especially important for individuals with swallowing difficulties or digestive sensitivities.
Also Read: Chia Seeds And Sabja Seeds Are Not The Same. Here's How To Tell Them Apart
Final Thoughts:
Chia seeds are undeniably powerful - but only when eaten right. Soak them, blend them, hydrate with them, and follow expert guidance to ensure you're gaining benefits without risking gut discomfort.
Advertisement
About Somdatta Saha Explorer- this is what Somdatta likes to call herself. Be it in terms of food, people or places, all she craves for is to know the unknown. A simple aglio olio pasta or daal-chawal and a good movie can make her day.
For the latest food news, health tips and recipes, like us on Facebook or follow us on Twitter and YouTube.
Tags:
Chia Seeds Benefits
How To Eat Chia Seeds
Dr Saurabh Sethi Chia Seeds
Show full article
Comments
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Print
24 minutes ago
- The Print
In battle for Indian anti-obesity market, Eli Lilly's pre-filled pen on one side, Novo Nordisk's on other
The Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorisation for Mounjaro in the KwikPen presentation, Eli Lilly said in a statement Thursday, adding that the approval marks an important step in advancing care for people living with type 2 diabetes and obesity in India. Mounjaro by US-based Eli Lilly & Company, which has tirzepatide as its active pharmaceutical ingredient (API), was launched in India on 20 March this year in vial format, which meant it was more cumbersome to administer. New Delhi: Eli Lilly India, makers of the obesity drug Mounjaro, said Thursday that they have received approvals from the Indian regulator for their pre-filled pen, a day after competitor Novo Nordisk's global mega-selling drug for obesity, Wegovy, hit the Indian markets. The pens offer a convenient way for patients to take their medication. First developed as a treatment for type 2 diabetes in lower doses, both Mounjaro and Wegovy are weekly injections intended to dramatically reduce weight in obese patients. They have emerged as global sensations in the pharmaceutical market world over, with their sales reaching multi-billion-dollar figures. These drugs have also been fighting to dominate the obesity management space in many developed countries. They are now aiming to capture a share of the market in India, where obesity is growing rapidly, driven by changing dietary and lifestyle patterns. India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore, and is projected to grow nearly eightfold to Rs 25,000 crore by 2030, according to market estimates. A 2023 survey by the Indian Council of Medical Research (ICMR) and Madras Diabetes Research Foundation (MDRF) had shown that 25.4 crore Indians, or 28.6 percent, of the population had generalised obesity. Obesity, now recognised as a chronic, relapsing disease, is a major risk factor for diabetes and is linked to over 200 health complications, including hypertension, dyslipidemia or high blood cholesterol, coronary heart disease, and obstructive sleep apnea. Also Read: Fat-busting drug Mounjaro launched in India. Here's how much it will cost Promise of simplified treatment KwikPen, or Mounjaro, is a multi-dose, prescription-based, single-patient-use pre-filled pen designed for once-weekly administration, the company said. It also added that the full range of doses for Mounjaro—2.5 mg to 15 mg—will be available in India soon, supporting personalised treatment as recommended by treating physicians. Earlier, the vial format of the drug was launched in only two dosage strengths—2.5 mg and 5 mg—in the country. The latest announcement came after Wegovy, which has semaglutide as its API, got a strategic launch in India as an innovative, easy-to-use pre-filled pen called FlexTouch devices. It was aimed at stealing the thunder Mounjaro had by reaching Indian patients first. A less potent version of semaglutide, in the form of an oral pill-under the brand name of Rybelsus, has been available in India since 2022 for the treatment of diabetes. The Wegovy pre-filled pen has been launched in five dosing strengths: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg. While the monthly cost of the first three dosages is Rs 17,345, the higher doses will cost Rs 24,280 and Rs 26,050, respectively. Mounjaro, in the vial format, was launched at a cost of Rs 14,000 (for 2.5 mg) and Rs 17,500. Eli Lilly, however, has yet to decide the price of the Mounjaro KwikPen for all five dosages. Meanwhile, experts ThePrint spoke to said pre-filled pens will simplify treatment, making these powerful anti-obesity and diabetes medications more convenient for patients. 'With simplified administration, adherence improves, helping more individuals achieve better weight and metabolic health outcomes,' explained Mumbai-based diabetologist Dr Rajiv Kovil. Senior diabetologist and researcher Dr V. Mohan also said this could make a profound impact on the lives of lakhs of people in India. Mounjaro vs Wegovy—which is more effective Both tirzepatide and semaglutide, the prescription-only drugs, mimic the effects of natural gut hormones that work by lowering caloric intake, primarily by influencing appetite control mechanisms. Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist, while semaglutide functions as a mono GLP-1 receptor agonist. Both GIP and GLP-1 are natural incretin hormones, that stimulate a decrease in blood glucose levels, found in brain regions that regulate appetite. In May this year, Lilly said in a statement that a head-to-head clinical trial comparing tirzepatide and semaglutide in their maximum tolerable doses showed the former to be significantly more effective than the latter in reducing both weight and waist circumference after 72 weeks of treatment. According to the US-based pharma giant, participants administered tirzepatide saw an average weight reduction of 20.2 percent, while those on semaglutide experienced a 13.7 percent loss—indicating a 47 percent greater relative weight loss for the former, based on the treatment regimen estimated at 72 weeks. But one advantage that semaglutide has in the higher dose strength is its ability to also treat several other metabolic conditions, such as cardiovascular diseases and kidney disorders. While Mounjaro is better than Wegovy in percentage of weight loss, there is stronger evidence in the case of Wegovy for reducing cardiovascular conditions in obese people without diabetes and also for treating kidney and diabetes, experts said. During the launch of Wegovy on 24 June, Novo Nordisk underlined that the drug is the only medication approved in India for treating major adverse cardiovascular events (MACE), along with obesity. Diabetologist Kovil said, 'If there is an obese patient who does not have other major underlying issues yet, I will be more inclined towards prescribing Mounjaro.' He added that, in patients with comorbidities such as diabetes, liver or kidney disorder or cardiovascular condition, Wegovy could be a better choice as it reduces mortality and improves longevity. In response to queries by ThePrint, Eli Lilly said that Mounjaro offers a novel approach to metabolic health management, giving treating physicians an innovative option for treating both diabetes and obesity. 'Ultimately, it is up to physicians to determine the most appropriate treatment based on individual patient needs and clinical judgment,' said the drugmaker. According to Dr Ambrish Mithal, chairman and head, endocrinology and diabetes with Max Healthcare, anti-obesity drugs can be indicated for people with a BMI (Body Mass Index) of 30 and above in the absence of other comorbidities. However, in people with other pre-existing conditions, either of the drugs can be initiated at a BMI of 27 and above, in conjunction with diet, lifestyle changes and under expert supervision, he said. Experts also warn about the possible side effects of GLP-1 agonist drugs amid concerns around misuse of these drugs in India, given the regulatory loopholes which allow patients to access most prescription drugs over the counter. Large clinical trials and post-marketing evidence following use of these medicines have shown that while nausea, bloating, vomiting and diarrhoea are comparatively mild side effects of these medications. In rare cases, they can also cause stomach paralysis, a disorder that affects the normal movement of the stomach muscles. In a response to queries by ThePrint, Eli Lilly emphasised that Mounjaro is a prescription-only drug and should be taken strictly under a doctor's supervision. 'Tirzepatide is not approved for, and should not be used for, cosmetic weight loss or by individuals under 18. Lilly neither promotes nor encourages the unapproved use of tirzepatide by anyone,' the company said. (Edited by Sanya Mathur) Also Read: Mounjaro will shrink India's appetite for packaged food, gyms, weight loss supplements
Time of India
37 minutes ago
- Time of India
Ayurveda's FMCG share remains low despite rising household use
Ayurveda, India's traditional healthcare system, accounts for just over 1% of the country's overall fast-moving consumer goods (FMCG) market despite leading companies launching hundreds of natural and herbal personal care products over the past few years. While 92% of Indian households purchased ayurvedic products in 2024-25 compared to 89% five years ago, the contribution of the segment to the total FMCG volume increased to 1.1% from 0.8% during the period, according to a new exclusive report by Kantar, consumer insights arm of WPP. Moreover, in 2024-25, sales of ayurvedic products by volume fell 1% year-on-year, its first decline ever, a sharp reversal from the high double-digit growth in recent years on the back of the meteoric rise of Patanjali, an Ayurveda-based brand by yoga guru Baba Ramdev and the Covid-19 pandemic-driven affinity for natural products. "Ayurvedic brands grew during the pandemic as consumers shifted focus on immunity. But most brands talk about natural ingredients and not many companies talk about ayurveda. In FY24, Patanjali drove the category growth and in FY25, their performance dragged the numbers down. While there are temporary hiccups, there is interest in the sector," said K Ramakrishnan, managing director, South Asia, Worldpanel Division. "While not falling under the traditional FMCG bracket, products with ingredients such as ashwagandha, triphala, shilajit are selling D2C (direct-to-consumer) and even on Q-Comm (quick commerce) channels, reaching the urban upper sections of society." Ayurvedic brands are those which use traditional principles and methods of ayurveda, while natural brands just add a few natural or herbs to their products. Dabur 's sales increased 3% year-on-year in 2024-25, Himalaya and Cholayil expanded 7.5% and 1.3%, respectively. However, sales of both Patanjali and Vicco fell 4% year-on-year, impacting the overall segment growth, said Kantar. "We have been taking steps to drive penetration of our healthcare brands and expanding the need state beyond immunity by getting into new areas like combating stress, digestion etc., besides expanding the consumer cohorts and increasing usage occasions. These have helped our key Ayurvedic brands maintain their momentum and record market share gains," said Dabur CEO Mohit Malhotra. He added that the company continued to add new products and offer age-old ayurvedic remedies in modern formats to better connect with the millennial consumers. Almost every household in India purchases at least one ayurvedic brand. with Dabur having the highest penetration (81%), followed by Patanjali (58%), according to Kantar. However, Patanjali, due to its presence across many categories, dominates with a higher volume share.
NDTV
2 hours ago
- NDTV
Potassium-Rich Summer Foods That Can Help You Control Blood Pressure
Maintaining healthy blood pressure numbers is critical for general well-being, especially during the hot summer months when our bodies are under stress. Diet, particularly potassium-rich foods, is an excellent strategy to regulate blood pressure. Potassium serves to regulate salt levels in the body, relaxes blood vessel walls, and supports heart function. Studies have also highlighted that adding potassium-rich foods to diet is an effective strategy to maintain healthy blood pressure. Here, we have a list of best summer foods for individuals with high blood pressure that are high in potassium. High potassium summer foods Foods high in potassium are good for blood pressure and health. Photo Credit: iStock 1. Bananas Bananas, a staple fruit in India, are high in potassium. They are readily available, inexpensive, and make an ideal snack. Incorporate bananas into your diet by blending them into smoothies, fruit salads, or simply eating them on their own. 2. Watermelon Watermelon is a pleasant summer fruit that is both hydrating and potassium-rich. This luscious fruit lowers blood pressure and provides a cooling effect. For a tasty treat, cut watermelon into slices, blend it into a juice, or mix it into a fruit salad. 3. Coconut water Coconut water is a natural electrolyte-rich beverage popular in India, particularly during the heat. It is high in potassium and helps to keep you hydrated and your blood pressure under control. 4. Spinach Spinach is a versatile leafy green that can be utilised in a variety of Indian recipes. It is rich in potassium and other vital minerals. To increase your potassium consumption, add spinach to salads, dal, palak paneer, or prepare a pleasant spinach smoothie. 5. Mangoes Mangoes, the king of fruits, are abundant during the summer and high in potassium. This delightful fruit not only fulfills your sweet craving but also helps to manage blood pressure. 6. Cucumber Cucumber is a hydrating vegetable rich in potassium and low in calories. It's ideal for summer and helps to keep your blood pressure constant. Cucumber slices can be added to salads, raitas, or eaten plain with a dash of salt and lime. 8. Tomatoes Tomatoes are a common element in many Indian recipes and a good source of potassium. They are suitable for use in salads, curries, chutneys, and sauces. Drinking a glass of tomato juice or including fresh tomatoes into your meals will help you maintain good blood pressure. 10. Yogurt Yogurt is an excellent probiotic and a good source of potassium. It cools, nourishes, and promotes good blood pressure. Include yogurt in your regular diet as lassi, chaas, or raita to reap the benefits. Foods to avoid 1. Processed foods Processed foods generally contain high quantities of sodium and preservatives, which can raise blood pressure. Avoid packaged snacks, quick noodles, and tinned food. 2. Pickles Pickles are a prominent component of Indian cuisine, yet they are often heavy in sodium. Limiting pickle eating can help control blood pressure. 3. Fried foods Fried meals, such as samosas and pakoras, are delicious but might raise blood pressure due to high fat and sodium levels. Choose healthier cooking methods, such as baking or grilling. 4. Papad Papads are a common complement to Indian dinners, although they can be rich in sodium. Even though they are light and crispy, eating them in big numbers might increase sodium intake, raising blood pressure. 5. Salted snacks Salted snacks such as chips, namkeen, and bhujiya are popular in India, however they are generally heavy in sodium. These can drastically elevate blood pressure. Choose unsalted nuts or fresh fruit instead. Adding potassium-rich foods to your summer diet is a natural and effective strategy to control blood pressure. Also avoid high sodium foods to maintain a balanced and heart-healthy diet. Disclaimer: This content including advice provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.
